Support

Conference Speakers

Cultural Speakers

Cultural practices, beliefs, and norms play a very important role not only in delivering health care to clients and patients, but also in how that health care is received and what outcomes are possible. Diversity within those beliefs and practices, and as a result of available resources or social economic/demographic circumstances, must be fully understood in order for health care professionals to provide the best care possible no matter where they are in the world, or what culture they are practicing within.

At GOLD Perinatal Care, we understand the importance of Culture and Diversity in health care, and we are working hard to bring you speakers and presentations from around the world that will help you understand the patients and clients you are working with. Discovering how health care is provided and received in other countries and cultures around the world can have a positive impact on our own professional practice. Given that culture is defined by much more than political borders, GOLD Perinatal Care invites speakers to share their knowledge and expertise about perinatal health care from a geographically-based focus or a people-group focus from within a particular set of beliefs, lifestyle or minority. This year, our Culture and Diversity speakers will be presenting on:

- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Dr. Second Speaker Name
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
View Registration Info
Speakers

Speakers (5191)

Sunday, 08 August 2021 11:17

Heather Wakelee

Written by
Dr. Heather Wakelee is a Professor of Medicine and Chief of the Division of Oncology at Stanford University in California, USA and the Deputy Director of the Stanford Cancer Institute. She is a graduate of Princeton University and Johns Hopkins University School of Medicine and completed her post-graduate training at Stanford University. Dr. Wakelee is the President-Elect of the International Association for the Study of Lung Cancer (IASLC); Co-Chair of the Thoracic Committee, Executive Committee member, and Stanford Principal Investigator for the Eastern Cooperative Oncology Group (ECOG-ACRIN), and she is a Fellow of the American Society of Clinical Oncology (FASCO). Dr. Wakelee has authored or co-authored over 200 medical articles on lung cancer and thymic malignancies and is involved in dozens of clinical trials. Her research focuses on many specific lung cancer subtypes defined by specific mutations in EGFR, ALK, ROS1, RET, BRAF and others. Additionally she focuses on adjuvant therapy including immunotherapy and anti-angiogenesis agents and has active collaborations with colleagues focused in biomarkers and population science research. She is passionate about mentorship and is proud of the many former trainees who are now working in faculty positions as lung cancer investigators and care providers.
Sunday, 08 August 2021 11:17

Zhuoxin Sun

Written by
Sunday, 08 August 2021 11:17

Yating Wang

Written by
Sunday, 08 August 2021 11:17

John Varlotto

Written by
Sunday, 08 August 2021 11:17

Keiju Aokage

Written by
Sunday, 08 August 2021 11:17

Els Wauters

Written by
Dr. Els Wauters is a deputy head of clinic at the Respiratory Oncology and Clinical trial Unit, Department of Pulmonology, University Hospitals Leuven, Belgium. She is also a Senior Academic Staff (ZAP) member of the Department of Chronic Diseases, Metabolism and Aging (CHROMETA), Faculty of Medicine, KU Leuven, Belgium. She is an active member of several national and international respiratory and oncology societies, such as ESMO, ASCO, IASLC, ETOP and ERS.

Dr. Wauters is devoted to providing the best possible care for her patients with lung and thoracic cancers. She has a special research interest in clinical trials of immunotherapy to treat lung cancer. She received a mandate for basic & clinical oncology research from Stichting tegen Kanker to perform research on biomarkers of efficacy of immune checkpoint inhibition immunotherapy, and she is supervising an FWO PhD fellowship on the toxicity (in particular pneumonitis) of immune checkpoint inhibition.
Sunday, 08 August 2021 11:17

Min Li

Written by
Prof. Min Li
Title: Professor, Master‘s Supervisor
Institute/Hospital: Department of Respiratory Medicine, Lung Cancer Center, Xiangya Hospital, Central South University
Vice-director of Respiratory and Critical Medicine Department, Xiangya Hospital, Central South University;
Vice-director of Clinical Research Center for Respiratory Diseases in Hunan Province;
Committee member of Lung Cancer Expert Committee, Chinese Society of Oncology;
Committee member of Lung Cancer Group of Respiratory Branch, Chinese Medical Association;
Committee member of Infectious Group of Respiratory Branch, Chinese Medical Doctor Association;
Youth member of Lung Cancer Professional Committee, China Anti-Cancer Association;
Youth member of Chinese Society of Clinical Oncology.
Sunday, 08 August 2021 11:17

Xuefeng Xia

Written by
Sunday, 08 August 2021 11:17

Chunliu Zhang

Written by
Sunday, 08 August 2021 11:17

Pansong Li

Written by
Page 341 of 371